GCP
GSA Capital Partners Portfolio holdings
AUM
$1.43B
1-Year Return
20.34%
This Quarter Return
+8.04%
1 Year Return
+20.34%
3 Year Return
+63.52%
5 Year Return
+120%
10 Year Return
+237.47%
AUM
$1.26B
AUM Growth
+$69.7M
(+5.9%)
Cap. Flow
+$20.2M
Cap. Flow
% of AUM
1.6%
Top 10 Holdings %
Top 10 Hldgs %
3.22%
Holding
2,074
New
640
Increased
457
Reduced
456
Closed
520
Top Buys
| 1 |
Monster Beverage
MNST
|
+$3.51M |
| 2 |
UGI
UGI
|
+$3.32M |
| 3 |
APA Corp
APA
|
+$3.31M |
| 4 |
Zoetis
ZTS
|
+$3.2M |
| 5 |
Lemonade
LMND
|
+$3.1M |
Top Sells
| 1 |
CRH
CRH
|
+$5.34M |
| 2 |
Aon
AON
|
+$4.58M |
| 3 |
Zillow
ZG
|
+$4.44M |
| 4 |
Kura Sushi USA
KRUS
|
+$4.13M |
| 5 |
Sprott Uranium Miners ETF
URNM
|
+$4.08M |
Sector Composition
| 1 | Technology | 16.16% |
| 2 | Financials | 12.35% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Healthcare | 11.74% |
| 5 | Industrials | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
First American
FAF
$6.91B
| $252K | 0.02% |
+4,132
| New | +$252K |
|
1302
Revolution Medicines
RVMD
$8.74B
| $251K | 0.02% |
+7,801
| New | +$251K |
|
1303
Kennametal
KMT
$1.59B
| $250K | 0.02% |
+10,018
| New | +$250K |
|
|
MREO
1304
Mereo BioPharma
MREO
$291M
| $250K | 0.02% |
+75,787
| New | +$250K |
|
1305
Supernus Pharmaceuticals
SUPN
$2.57B
| $249K | 0.02% |
7,294
-1,031
| -12% | -$35.2K |
|
1306
National Presto Industries
NPK
$807M
| $248K | 0.02% |
+2,964
| New | +$248K |
|
1307
USA Compression Partners
USAC
$2.99B
| $248K | 0.02% |
+9,304
| New | +$248K |
|
1308
Valvoline
VVV
$5.12B
| $248K | 0.02% |
5,554
-41,818
| -88% | -$1.87M |
|
1309
LeMaitre Vascular
LMAT
$2.09B
| $247K | 0.02% |
3,720
-6,105
| -62% | -$405K |
|
1310
Medpace
MEDP
$13.9B
| $247K | 0.02% |
+611
| New | +$247K |
|
1311
CNB Financial Corp
CCNE
$763M
| $246K | 0.02% |
12,087
-10,428
| -46% | -$212K |
|
|
WMPN
1312
DELISTED
William Penn Bancorporation Common Stock
WMPN
| $246K | 0.02% |
19,918
+3,883
| +24% | +$48K |
|
1313
Olo Inc
OLO
$1.74B
| $245K | 0.02% |
44,606
-121,337
| -73% | -$666K |
|
1314
Robert Half
RHI
$3.62B
| $245K | 0.02% |
+3,088
| New | +$245K |
|
|
SUM
1315
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $245K | 0.02% |
5,491
-31,803
| -85% | -$1.42M |
|
1316
Clover Health Investments
CLOV
$1.55B
| $244K | 0.02% |
307,728
+56,138
| +22% | +$44.5K |
|
1317
SPDR S&P Global Natural Resources ETF
GNR
$3.32B
| $244K | 0.02% |
+4,219
| New | +$244K |
|
1318
Royalty Pharma
RPRX
$15.8B
| $244K | 0.02% |
8,041
-6,196
| -44% | -$188K |
|
1319
Sangamo Therapeutics
SGMO
$154M
| $244K | 0.02% |
364,284
-711,406
| -66% | -$477K |
|
1320
Veeva Systems
VEEV
$45.3B
| $244K | 0.02% |
+1,051
| New | +$244K |
|
1321
Hanmi Financial
HAFC
$753M
| $243K | 0.02% |
15,283
-75,464
| -83% | -$1.2M |
|
1322
Nexstar Media Group
NXST
$6.28B
| $243K | 0.02% |
+1,409
| New | +$243K |
|
1323
Commault Systems
CVLT
$7.81B
| $242K | 0.02% |
2,383
-7,209
| -75% | -$732K |
|
1324
GSI Technology
GSIT
$96.6M
| $242K | 0.02% |
+71,042
| New | +$242K |
|
1325
Luminar Technologies
LAZR
$127M
| $242K | 0.02% |
+8,177
| New | +$242K |
|